Prostate cancer screening rates declined over a 7-year period ending in 2014, even in higher-risk groups, according to a study involving more >160,000 individuals. Participants were ≥40 years of age. Investigators looked at annual PSA screening rates, as well as frequency of re-screening and prostate biopsies. Among the results:

• Annual screening rates declined from 23% to 9% in men ≥70 years of age.
• In patients aged 50 to 69 years and 40 to 49 years, rates declined from 39% to 20%, and from 11% to 5%, respectively.
• Overall rates were lower for blacks.
• Rates were similar or slightly higher in men with a family history of prostate cancer.
• Clinician variation in PSA test ordering did not change substantially after release of USPSTF recommendations.
• Similar re-screening rates were seen in men aged 45 to 75 with initial PSA levels of <1 or 1-3 ng/mL whether they were screened earlier or later during the evaluation period.